CASI
Price
$2.02
Change
+$0.02 (+1.00%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
30.68M
IOVA
Price
$3.36
Change
+$0.17 (+5.33%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
1.05B
19 days until earnings call
Ad is loading...

CASI vs IOVA

Header iconCASI vs IOVA Comparison
Open Charts CASI vs IOVABanner chart's image
CASI Pharmaceuticals
Price$2.02
Change+$0.02 (+1.00%)
Volume$100
Capitalization30.68M
Iovance Biotherapeutics
Price$3.36
Change+$0.17 (+5.33%)
Volume$231.74K
Capitalization1.05B
CASI vs IOVA Comparison Chart
Loading...
CASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IOVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CASI vs. IOVA commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CASI is a StrongBuy and IOVA is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (CASI: $2.00 vs. IOVA: $3.19)
Brand notoriety: CASI and IOVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CASI: 30% vs. IOVA: 67%
Market capitalization -- CASI: $30.68M vs. IOVA: $1.05B
CASI [@Biotechnology] is valued at $30.68M. IOVA’s [@Biotechnology] market capitalization is $1.05B. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CASI’s FA Score shows that 0 FA rating(s) are green whileIOVA’s FA Score has 0 green FA rating(s).

  • CASI’s FA Score: 0 green, 5 red.
  • IOVA’s FA Score: 0 green, 5 red.
According to our system of comparison, IOVA is a better buy in the long-term than CASI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CASI’s TA Score shows that 4 TA indicator(s) are bullish while IOVA’s TA Score has 5 bullish TA indicator(s).

  • CASI’s TA Score: 4 bullish, 3 bearish.
  • IOVA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, IOVA is a better buy in the short-term than CASI.

Price Growth

CASI (@Biotechnology) experienced а +3.63% price change this week, while IOVA (@Biotechnology) price change was +3.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.07%. For the same industry, the average monthly price growth was -6.06%, and the average quarterly price growth was -12.59%.

Reported Earning Dates

CASI is expected to report earnings on Mar 31, 2025.

IOVA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+7.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IOVA($1.05B) has a higher market cap than CASI($30.7M). CASI YTD gains are higher at: -29.329 vs. IOVA (-56.892). CASI has higher annual earnings (EBITDA): -31.62M vs. IOVA (-351.67M). IOVA has more cash in the bank: 324M vs. CASI (20.8M). CASI has less debt than IOVA: CASI (19.1M) vs IOVA (58.3M). IOVA has higher revenues than CASI: IOVA (164M) vs CASI (22.1M).
CASIIOVACASI / IOVA
Capitalization30.7M1.05B3%
EBITDA-31.62M-351.67M9%
Gain YTD-29.329-56.89252%
P/E RatioN/AN/A-
Revenue22.1M164M13%
Total Cash20.8M324M6%
Total Debt19.1M58.3M33%
FUNDAMENTALS RATINGS
CASI vs IOVA: Fundamental Ratings
CASI
IOVA
OUTLOOK RATING
1..100
246
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
37
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9695
PRICE GROWTH RATING
1..100
8693
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IOVA's Valuation (37) in the Biotechnology industry is somewhat better than the same rating for CASI (76). This means that IOVA’s stock grew somewhat faster than CASI’s over the last 12 months.

IOVA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CASI (100). This means that IOVA’s stock grew similarly to CASI’s over the last 12 months.

IOVA's SMR Rating (95) in the Biotechnology industry is in the same range as CASI (96). This means that IOVA’s stock grew similarly to CASI’s over the last 12 months.

CASI's Price Growth Rating (86) in the Biotechnology industry is in the same range as IOVA (93). This means that CASI’s stock grew similarly to IOVA’s over the last 12 months.

CASI's P/E Growth Rating (100) in the Biotechnology industry is in the same range as IOVA (100). This means that CASI’s stock grew similarly to IOVA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CASIIOVA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 8 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
CASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IOVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YQ1.820.19
+11.36%
17 Education & Technology Group
JAKK19.080.38
+2.03%
JAKKS Pacific
ALC93.700.39
+0.42%
Alcon
LQDA13.540.05
+0.37%
Liquidia Corp
FIZZ43.88-0.84
-1.88%
National Beverage Corp

CASI and

Correlation & Price change

A.I.dvisor tells us that CASI and ASND have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CASI and ASND's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CASI
1D Price
Change %
CASI100%
+1.01%
ASND - CASI
33%
Poorly correlated
-0.62%
RIGL - CASI
29%
Poorly correlated
+2.37%
IOVA - CASI
26%
Poorly correlated
-0.62%
ORMP - CASI
26%
Poorly correlated
+0.66%
SNPX - CASI
26%
Poorly correlated
+8.28%
More

IOVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IOVA has been loosely correlated with CRSP. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if IOVA jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IOVA
1D Price
Change %
IOVA100%
-0.62%
CRSP - IOVA
51%
Loosely correlated
-1.76%
DNLI - IOVA
48%
Loosely correlated
+1.85%
RCKT - IOVA
48%
Loosely correlated
+2.44%
XENE - IOVA
48%
Loosely correlated
+2.23%
ETNB - IOVA
46%
Loosely correlated
+0.92%
More